Welcome to Hodoodo Chemicals

Sulfanilamide
featured

WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H318772

CAS#: 63-74-1

Description: Sulfanilamide is a sulfonamide antibacterial. Chemically, it is an organic compound consisting of an aniline derivatized with a sulfonamide group. sulfanilamide remains in use for treatment of vaginal yeast infections.

Chemical Structure

Sulfanilamide

CAS# 63-74-1

Instruction

Theoretical Analysis

Hodoodo Cat#: H318772
Name: Sulfanilamide
CAS#: 63-74-1
Chemical Formula: C6H8N2O2S
Exact Mass: 172.03
Molecular Weight: 172.202
Elemental Analysis: C, 41.85; H, 4.68; N, 16.27; O, 18.58; S, 18.62

Price and Availability

Size	Price	Availability
25g	USD 350	2 Weeks
100g	USD 550	2 Weeks
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. Hodoodo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Synonym: F1162; F-1162; F 1162; Sulfanilamide; Gerison; Gombardol

IUPAC/Chemical Name: 4-aminobenzenesulfonamide

InChi Key: FDDDEECHVMSUSB-UHFFFAOYSA-N

InChi Code: InChI=1S/C6H8N2O2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,7H2,(H2,8,9,10)

SMILES Code: O=S(C1=CC=C(N)C=C1)(N)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Instruction:

View handling instruction

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 172.20 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: Scozzafava A, Supuran CT. Glaucoma and the applications of carbonic anhydrase inhibitors. Subcell Biochem. 2014;75:349-59. doi: 10.1007/978-94-007-7359-2_17. Review. PubMed PMID: 24146387.

2: Hammoudeh DI, Zhao Y, White SW, Lee RE. Replacing sulfa drugs with novel DHPS inhibitors. Future Med Chem. 2013 Jul;5(11):1331-40. doi: 10.4155/fmc.13.97. Review. PubMed PMID: 23859210; PubMed Central PMCID: PMC3869102.

3: Rodrigues Gda S, Severo CB, Oliveira Fde M, Moreira Jda S, Prolla JC, Severo LC. Association between paracoccidioidomycosis and cancer. J Bras Pneumol. 2010 May-Jun;36(3):356-62. Review. English, Portuguese. PubMed PMID: 20625674.

4: Krungkrai J, Supuran CT. The alpha-carbonic anhydrase from the malaria parasite and its inhibition. Curr Pharm Des. 2008;14(7):631-40. Review. PubMed PMID: 18336308.

5: Krungkrai J, Krungkrai SR, Supuran CT. Malarial parasite carbonic anhydrase and its inhibitors. Curr Top Med Chem. 2007;7(9):909-17. Review. PubMed PMID: 17504136.

6: Nzila A. Inhibitors of de novo folate enzymes in Plasmodium falciparum. Drug Discov Today. 2006 Oct;11(19-20):939-44. Epub 2006 Sep 7. Review. PubMed PMID: 16997145.

7: Gupta A, Waldhauser LK. Adverse drug reactions from birth to early childhood. Pediatr Clin North Am. 1997 Feb;44(1):79-92. Review. PubMed PMID: 9057785.

8: Dallegri F, Ottonello L, Bevilacqua M. Possible modes of action of nimesulide in controlling neutrophilic inflammation. Arzneimittelforschung. 1995 Oct;45(10):1114-7. Review. PubMed PMID: 8595071.

9: Miller VA, Rigas JR, Grant SC, Pisters KM, Kris MG. New chemotherapeutic agents for non-small cell lung cancer. Chest. 1995 Jun;107(6 Suppl):306S-311S. Review. PubMed PMID: 7781411.

10: Gendeleka GF, Lakiza VV. [The sulfanilamide resistance of patients with type-2 diabetes mellitus]. Lik Sprava. 1993 Apr;(4):51-6. Review. Russian. PubMed PMID: 8209448.

11: Fisherman JS, Osborn BL, Chun HG, Plowman J, Smith AC, Christian MC, Zaharko DS, Shoemaker RH. Chloroquinoxaline sulfonamide: a sulfanilamide antitumor agent entering clinical trials. Invest New Drugs. 1993 Feb;11(1):1-9. Review. PubMed PMID: 8349430.

12: Hodel C, Bass R. Are newer scientific concepts in regulatory toxicology used timely and appropriately? Toxicol Lett. 1992 Dec;64-65 Spec No:149-55. Review. PubMed PMID: 1471168.

13: Trubnikov GV. [Eosinophilic lesions of the lungs (case reports and review of the literature)]. Ter Arkh. 1991;63(3):108-14. Review. Russian. PubMed PMID: 2063320.

14: Bricaire F, Salmon D, Danis M, Gentilini M. [Antimalarials and pregnancy]. Bull Soc Pathol Exot. 1991;84(5 Pt 5):721-38. Review. French. PubMed PMID: 1819422.

15: Paul O. Background of the prevention of cardiovascular disease. II. Arteriosclerosis, hypertension, and selected risk factors. Circulation. 1989 Jul;80(1):206-14. Review. PubMed PMID: 2661054.

16: Benziger DP, Edelson J. Absorption from the vagina. Drug Metab Rev. 1983;14(2):137-68. Review. PubMed PMID: 6301793.

17: Mordkovskaia NM. [The present status of the question of the mechanism of action of sulfanilamide hypoglycemic preparations and several aspects of their use in the treatment of diabetes mellitus]. Probl Endokrinol (Mosk). 1971 Sep-Oct;17(5):121-5. Review. Russian. PubMed PMID: 4337075.

18: Guseva LN. [Methods for quantitative determination of sulfanilamide preparations]. Aptechn Delo. 1966 Jul-Aug;15(4):74-8. Review. Russian. PubMed PMID: 4866578.

19: YOW EM. A CRITICAL APPRAISAL OF THE SULFONAMIDES. Med Times. 1965 Sep;93:917-25. Review. PubMed PMID: 14338831.

20: PORTER IH. GENETIC BASIS OF DRUG METABOLISM IN MAN. Toxicol Appl Pharmacol. 1964 Sep;6:499-511. Review. PubMed PMID: 14216991.

Your view history

Sulfanilamide featured